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Data in this article show radioligand uptake (to gamma counter
and positron-emission-tomography) as well as polymerase chain
reaction analyses of 18 kDa translocator protein (TSPO) quantiﬁ-
cation. We conﬁrmed speciﬁcity of [18F]GE180 binding of rodent
brain and myocardium by blocking experiments with prior appli-
cation of non-radioactive GE180, using dynamic in vivo positron-
emission-tomography and ex vivo gamma counter measurements.vier Inc. This is an open access article under the CC BY license
.neuroimage.2017.10.006
enchen.de (M. Brendel).
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M. Deussing et al. / Data in Brief 19 (2018) 331–336332Expression of TSPO was compared between rodent brain and
myocardium by quantitative polymerase chain reaction.
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Nuclear Medicine
ore speciﬁc subject area Preclinical PET imaging of neuroinﬂammation
ype of data PET images, blocking plots, correlation plots
ow data was acquired [18F]GE180 TSPO PET, gamma counter, TSPO qPCR
ata format Quantiﬁcation of PET and tissue samples, Listmode, NIFTI
xperimental factors C57Bl6 mice, cold GE180, [18F]GE180, Analysis of TSPO expression
xperimental features TSPO PET, TSPO qPCR
ata source location Department of Nuclear Medicine, Munich, Germany
ata accessibility The data is provided within this articleValue of the data
 Blocking by pretreatment with non-radioactive GE180 for quantiﬁcation of speciﬁc [18F]GE180
TSPO binding in rodent brain and myocardium to positron-emission-tomography.
 Regional analysis for characterization of [18F]GE180 binding speciﬁcity in different areas of the
rodent brain.
 Data provide information about the physiological relationship between speciﬁc 18 kDa translocator
protein (TSPO) tracer signal in normal rodent brain and myocardium.
 Quantitative polymerase chain reaction gives additional information about the relative magnitudes
of TSPO expression in brain and myocardium.1. Data
We observed that the myocardium presents a potential extra-cerebral reference region for [18F]
GE180 TSPO positron-emission-tomography quantitation [1]. The following data provide additional
information about the association and speciﬁcity of brain and myocardium TSPO tracer binding, as
obtained by blocking experiments (Fig. 1, Fig. 2). Furthermore, we performed quantitative polymerase
chain reaction for assessment of TSPO gene expression in brain and myocardium, independent of
tracer-based measurements (Fig. 3).2. Experimental design, materials and methods
2.1. Radiochemistry
Radiosynthesis of [18F]GE180 was performed as previously described [3], with slight modiﬁcations
[4], in a procedure yielding radiochemical purity 4 98%, and speciﬁc activity of 1400 7 500 GBq/
mmol at end of synthesis. For blocking, non-radioactive GE180 was used at a mass concentration ratio
of 1000:1 compared to the radiolabeled ligand.
Fig. 2. Dynamic and regional in vivo positron-emission-tomography (PET) measurements of the brain. (A) Mean dynamic brain
PET standardized uptake value (SUV) plots for groups of unblocked (blue) and blocked (red) mice during 90min after injection
of [18F]GE180. Error bars indicate standard deviations. (B) Regional analysis shows axial slices of 60–90min [18F]GE180 PET SUV
projected upon a magnetic resonance imaging template [2]. Upper row illustrates mice with prior blocking by a large mass dose
of GE180 (1000:1), whereas the middle row shows unblocked mice. Voxel-wise percentage of speciﬁc binding in the rodent
brain is depicted in the bottom row. Highest speciﬁc binding was observed in regions with high abundance of ependymal glia
cells, e.g. adjacent to the fourth ventricle, whereas speciﬁc binding in the cortex was low. Data derive from N ¼ 3 unblocked
and N ¼ 5 blocked C57Bl/6 mice at seven months of age. Error bars indicate standard deviations. Single data points are
available in the supplement.
Fig. 1. Gamma counter measurements of tracer uptake in brain and myocardium ex vivo. (A) Bar graphs (logarithmic scale)
show %-injected dose-(ID)/g at 107min after injection of [18F]GE180 with (red) and without (blue) prior blocking with excess
non-radioactive GE180 (1000:1). Speciﬁc binding was estimated to be 36% in the brain and 80% in the myocardium. Absolute
speciﬁc binding was 17-fold higher in the myocardium when compared to the brain. (B) Correlation between %-ID/g of brain
and myocardium in single mice indicate a relationship between speciﬁc TSPO tracer binding in the two tissues, whereas
nonspeciﬁc binding did not correlate (R2 o 0.2). Data derive from N ¼ 5 unblocked and N ¼ 7 blocked C57Bl/6 mice at seven
months of age. Error bars indicate standard deviations. Single data points are available in the supplement.
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We performed blocking experiments with excess non-radioactive tracer for quantiﬁcation of
speciﬁc [18F]GE180 binding components in the rodent brain and myocardium. A total of twelve female
C57Bl6 mice were analyzed at the age of seven months. Isoﬂurane anesthesia (1.5% in 2–4 l/min O2)
Fig. 3. Quantitative polymerase chain reaction assessment of TSPO gene expression in brain and myocardium. Bar graphs show
relative normalized (actin-beta and glyceraldehyde 3-phosphate dehydrogenase) TSPO expression as assessed by the quanti-
tative polymerase chain reaction. TSPO expression was 11-fold higher in the myocardium compared to that in brain. Data derive
from N ¼ 6 C57Bl/6 mice at seven months of age. Error bars indicate standard deviations. Single data points are available in the
supplement.
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itation at 107min post injection, while in a state of deep narcosis. Five mice received an injection of
14.7 7 2.2MBq [18F]GE180 into the tail vein (150 ml saline) Seven mice received an injection of excess
non-radioactive GE180 (1000:1) prior to injection of 14.5 7 2.1MBq [18F]GE180 (in 150 ml saline) to a
tail vein. Brain and myocardium tissues were quickly removed, and radioactivity concentration was
measured in a gamma counter (Cobra Quantum 5002, Packard) with decay-correction to time of
tracer injection [5].2.3. Positron-emission-tomography acquisition and analysis
A subset of mice (N ¼ 5 with blocking and N ¼ 3 without blocking) was placed in the tomograph
(Siemens Inveon DPET) immediately after injection of [18F]GE180, whereupon we began a 90min
dynamic emission recording as described previously [6]. A 15min transmission scan was then
obtained using a rotating [57Co] point source. The image reconstruction procedure consisted of three-
dimensional ordered subset expectation maximization with four iterations and twelve subsets fol-
lowed by a maximum a posteriori algorithmwith 32 iterations. Framing was 3  60 s, 6  180 s, 9 
300 s, 3  600 s. Scatter and attenuation correction were performed and a decay correction for [18F]
was applied. With a zoom factor of 1.0 and a 128  128  159 matrix, a ﬁnal voxel dimension of 0.78
 0.78  0.80mm was obtained.
Summations of the dynamic emission datasets were manually co-registered to a magnetic reso-
nance imaging mouse atlas [2] by a rigid-body transformation using the PMOD fusion tool (V3.5,
PMOD Technologies Ltd.), after blinding the reader to the mouse status (blocked/unblocked). In the
second step, a reader-independent automatic re-registration to tracer-speciﬁc templates was per-
formed, as reported previously [7]. Initial manual positron-emission-tomography to magnetic reso-
nance imaging atlas fusion images were normalized by non-linear brain normalization to the tem-
plate using the PMOD brain normalization tool (equal modality; smoothing by 0.6mm; nonlinear
warping; 16 iterations; frequency cutoff 3; regularization 1.0; no thresholding). The concatenation of
both transformations was then applied to positron-emission-tomography frames in the native space,
to obtain optimal resampling with a minimum of interpolation. The whole brain [18F]GE180 con-
centration (standardized uptake value; SUV) was measured in a volume-of-interest deﬁned by the
magnetic resonance imaging template. The volume-of-interest, comprising 525mm3, included the
entire cerebrum, cerebellum, brainstem and olfactory bulb. The 60–90min image frames were used to
calculate voxel-wise percentages of speciﬁc [18F]GE180 binding throughout the rodent brain.
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3.1. RNA isolation and reverse transcription
Brain and heart tissue from adult mice was immediately frozen to  80 °C in liquid nitrogen after
resection. Tissue was lysed with QIAzol Lysis Reagent (Quiagen) and homogenized. The InviTraps
Spin Universal RNA Mini Kit (Stratec) was used to isolate RNA and to separate it from contaminating
DNA. RNA concentration was measured with NanoDrop™ 2000 Spectrophotometer (Thermo Fisher
Scientiﬁc, Waltham, MA, USA). Extracted RNA was assessed based on spectral data and purity ratios
(A260/A280). Reverse transcription from 50 mL of 50 ng/mL RNA was performed by incubating with 4 m
L 25x dNTPs, 10 mL 10x random primers, 5 mL MultiScribe™ Reverse Transcriptase 50 U/mL, 21 mL
Nuclease-free H2O for 10min at 25 °C, then 120min at 37 °C. The transcription was terminated by
incubating at 85 °C for 5min.
3.2. Real-time polymerase chain reaction
TSPO mRNA expression was measured using a CFX connect optics module RT-System (BioRad,
Hercules, CA, USA). cDNA template 9 ml was added to 20 TaqMans Gene Expression Assay
Mm00437828_m1 1 ml and 2x TaqMans Gene Expression Master Mix 10 ml. Thermal cycling condi-
tions were 2min at 50 °C and 10min at 95 °C, followed by 40 cycles at 98 °C for 15 s and at 60 °C for 1
min. To test speciﬁcity of the polymerase chain reaction product a melt curve analysis was performed.
TSPO expression was normalized to the housekeeping genes Actin-beta and glyceraldehyde 3-
phosphate dehydrogenase expression was used for comparative quantiﬁcation.Acknowledgements
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